However, the literature suggests that mTOR is already upregulated in Alzheimer disease brains (Tramutola et al., 2015), animal models (Caccamo et al., 2018), and in Down Syndrome (Perluigi et al., 2014) whose patients exhibit accelerated AD pathogenesis. Here, MTOR is linked to Alzheimer disease.